The cost-effectiveness of pharmacist-led treatment of cardiac risk in patients with type 2 diabetes

被引：0
|
作者：
Andrew Lowey
Sara Moore
Catherine Norris
David Wright
Jonathan Silcock
Peter Hammond
机构：
[1] Harrogate & District Foundation Trust,Pharmacy Department
[2] Leeds Teaching Hospitals NHS Trust,Pharmacy Department, Gledhow Wing
[3] St. James University Hospital,School of Chemical Sciences and Pharmacy
[4] University of East Anglia,Pharmacy Practice and Medicines Management Group
[5] University of Leeds,undefined
来源：
Pharmacy World & Science | 2007年 / 29卷
关键词：
Diabetes mellitus; Hypertension; Hyperlipidaemia; Pharmacy; Cost-effectiveness; Cardiovascular risk; United Kingdom; Pharmacoeconomics; Pharmacist;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：541 / 545
页数：4
相关论文
共 50 条
  • [1] The cost-effectiveness of pharmacist-led treatment of cardiac risk in patients with type 2 diabetes
    Lowey, Andrew
    Moore, Sara
    Norris, Catherine
    Wright, David
    Silcock, Jonathan
    Hammond, Peter
    [J]. PHARMACY WORLD & SCIENCE, 2007, 29 (05): : 541 - 545
  • [2] LONG-TERM COST-EFFECTIVENESS OF A PHARMACIST-LED MEDICATION THERAPY MANAGEMENT CLINIC (MTMC) FOR TYPE 2 DIABETES MANAGEMENT
    Joshi, M.
    Pham, C. M.
    Deng, H.
    Norton, R. M.
    Mathew, S.
    Tilton, J. J.
    Touchette, D. R.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S386 - S386
  • [3] EFFECTIVENESS OF A PHARMACIST-LED MEDICATIONS MANAGEMENT SERVICE FOR ADULTS WITH TYPE 2 DIABETES MELLITUS
    Cheen, H. H. M.
    Martin, A. J.
    Lim, P. S.
    Chen, L. L.
    Lim, S. H.
    Chow, M. M. Y.
    Lim, J. C.
    Khee, G. Y.
    Wee, H. L.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S95 - S95
  • [4] Cost-effectiveness of treatment of type 2 diabetes
    Eastman, RC
    [J]. DIABETES CARE, 1998, 21 (03) : 464 - 465
  • [5] Pharmacist-Led Shared Medical Appointments for Multiple Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
    Cohen, Lisa B.
    Taveira, Tracey H.
    Khatana, Sameed Ahmed M.
    Dooley, Andrea G.
    Pirraglia, Paul A.
    Wu, Wen-Chih
    [J]. DIABETES EDUCATOR, 2011, 37 (06): : 801 - 812
  • [6] Cost-Effectiveness of Pharmacist-Led Deprescribing of NSAIDs in Community-Dwelling Older Adults
    Sanyal, Chiranjeev
    Turner, Justin P.
    Martin, Philippe
    Tannenbaum, Cara
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 68 (05) : 1090 - 1097
  • [7] Cost-Effectiveness of a Community Pharmacist-Led Sleep Apnea Screening Program - A Markov Model
    Perraudin, Clemence
    Le Vaillant, Marc
    Pelletier-Fleury, Nathalie
    [J]. PLOS ONE, 2013, 8 (06):
  • [8] Cost-Effectiveness Analysis of a Pharmacist-Led Medication Therapy Management Program: Hypertension Management
    Schultz, Bob G.
    Tilton, Jessica
    Jun, Julie
    Scott-Horton, Tiffany
    Quach, Danny
    Touchette, Daniel R.
    [J]. VALUE IN HEALTH, 2021, 24 (04) : 522 - 529
  • [9] COST-EFFECTIVENESS OF ADDING A PHARMACIST TO THE PRIMARY CARE TEAM FOR THE MANAGEMENT OF TYPE 2 DIABETES PATIENTS
    Yu, J.
    Shah, B.
    Ip, E. J.
    Chan, J.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A181 - A181
  • [10] COST-EFFECTIVENESS ANALYSIS OF A PHARMACIST-LED INTERVENTION ON IMPROVING INHALER ADHERENCE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    van Boven, J. F.
    Tommelein, E.
    Boussely, K.
    Mehuys, E.
    Vegter, S.
    Blusselle, G. G.
    Rutten-van Molken, M. P. M. H.
    Postma, M. J.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A136 - A136
12345